tiprankstipranks
Trending News
More News >
Actinium Pharmaceuticals (ATNM)
:ATNM
US Market

Actinium Pharmaceuticals (ATNM) Income Statement

Compare
2,267 Followers

Actinium Pharmaceuticals Income Statement

Last quarter (Q3 2025), Actinium Pharmaceuticals's total revenue was $90.00K, an increase of Infinity% from the same quarter last year. In Q3, Actinium Pharmaceuticals's net income was $-5.13M. See Actinium Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 81.00K$ 1.03M$ 1.14M$ 0.00
Gross Profit
$ -811.00K$ 81.00K$ 1.03M$ 620.00K$ -447.00K
Operating Expenses
$ 41.31M$ 52.00M$ 35.13M$ 25.58M$ 21.95M
Depreciation and Amortization
$ 811.00K$ 790.00K$ 699.00K$ 524.00K$ 447.00K
EBITDA
$ -37.43M$ -51.13M$ -33.41M$ -24.25M$ -21.77M
Operating Income
$ -42.12M$ -51.92M$ -34.10M$ -24.96M$ -22.39M
Other Income/Expenses
$ 3.88M$ 3.10M$ 1.09M$ 190.00K$ 178.00K
Pretax Income
$ -38.24M$ -48.82M$ -33.02M$ -24.77M$ -22.21M
Net Income
$ -38.24M$ -48.82M$ -33.02M$ -24.77M$ -22.21M
Per Share Metrics
Basic EPS
$ -1.27$ -1.83$ -1.37$ -1.20$ -1.83
Diluted EPS
$ -1.27$ -1.83$ -1.37$ -1.20$ -1.83
Weighted Average Shares Outstanding
30.07M 26.60M 24.14M 20.57M 12.13M
Weighted Average Shares Outstanding (Diluted)
30.07M 26.60M 24.14M 20.57M 12.13M
Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History